A digital tool to empower adults with congenital heart disease
Official title: Improving Care for Adults With Congenital Heart Disease
Run by University of California, San Francisco · NCT06581484 · Data updated 2026-11-12
This study is testing a digital tool called 'Empower My Congenital Health' to see if it helps adults with congenital heart disease feel more confident and engaged in managing their health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (San Francisco, California) |
| Status | Recruiting |
| Started | September 5, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | August 31, 2027 |
| Registry record updated | January 23, 2026 |
| Trial ID | NCT06581484 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who have congenital heart disease and can provide informed consent.
✕Probably not a fit
Patients who are developmentally delayed or unable to consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates a digital health intervention called 'Empower My Congenital Health' designed to enhance the engagement and self-advocacy skills of adults with congenital heart disease (CHD). The intervention includes features such as a digital medical passport, health information, community support, and reminders for specialist visits. Participants will be recruited from clinics and through various outreach methods, and their engagement will be assessed through surveys at regular intervals. The study aims to determine if this intervention improves patient confidence in navigating the healthcare system.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the ability of adults with congenital heart disease to manage their health and access necessary care.
How similar studies have gone: Other studies have shown promise in using digital interventions for patient engagement, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * have congenital heart disease * 18 years or older * can sign the informed consent Exclusion Criteria: * developmentally delayed * unable to consent
Where it's running
-
University of California, San Francisco
San Francisco, California, United States Recruiting
Study contacts
- Principal investigator: Anushree Agarwal, MBBS, MAS — University of California, San Francisco
- Study coordinator: Anushree Agarwal, MBBS, MAS
- Email: anu.agarwal2@ucsf.edu
- Phone: 415-353-3817
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Senior Center Medication Safety and Empowerment Curriculum
A program for adults 55+ and their care partners to learn how to safely manage medications and talk with doctors about safer options.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates
A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.
-
Screening for lipid disorders in children and teens with chronic diseases to flag cardiovascular risk
This study tests a blood test and a questionnaire to screen children and teens with chronic conditions for lipid metabolism disorders and familial hyperlipidemia.
-
Prehabilitation before heart surgery for adults with congenital heart disease
This study is testing whether a tailored, supervised exercise program before heart surgery helps adults with congenital heart disease perform better and improve fitness.
-
Accessible care model comparing nurse-led versus physician-led transition education for teens and young adults with congenital heart disease
This project will test whether an accessible care model and nurse-led versus physician-led transition education helps teens and young adults (ages 12–26) with congenital heart disease move successfully from pediatric to adult heart care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.